Millennium Management’s 10x Genomics TXG Stock Holding History

Millennium Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.01M	Buy	+377,300	New	+$7.54M	﹤0.01%	2401
2025 Q3	–	Sell	-60,000	Closed	-$695K	–	6485
2025 Q2	$695K	Buy	+60,000	New	+$547K	﹤0.01%	4672
2025 Q1	–	Sell	-15,000	Closed	-$215K	–	6408
2024 Q4	$215K	Sell	15,000 -55,000	-79%	-$868K	﹤0.01%	5272
2024 Q3	$1.58M	Buy	+70,000	New	+$1.45M	﹤0.01%	3916
2022 Q3	–	Sell	-10,000	Closed	-$453K	–	7509
2022 Q2	$453K	Buy	+10,000	New	+$519K	﹤0.01%	5042
2022 Q1	–	Sell	-2,000	Closed	-$298K	–	7504
2021 Q4	$298K	Buy	+2,000	New	+$306K	﹤0.01%	5552

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's TXG Position: Q1 2026 in Review

Millennium Management increased its 10x Genomics (TXG) stake by 66% in Q1 2026, buying an estimated $16.5M and bringing the position to 2,068,414 shares worth $43.9M. The position accounts for 0.02% of the portfolio, ranked #918.

Millennium Management first reported a position in TXG in Q3 2019 and has held it in 24 quarters since. The position peaked at $63.6M in Q3 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Millennium Management held 2,068,414 shares of 10x Genomics worth $43.9M as of Q1 2026.
Millennium Management bought 826,048 10x Genomics shares in Q1 2026, an estimated $16.5M.
10x Genomics made up 0.02% of Millennium Management's portfolio in Q1 2026, its #918 holding.
Millennium Management first reported a position in 10x Genomics in Q3 2019 and has held it in 24 quarters since.
Millennium Management's 10x Genomics position peaked at $63.6M in Q3 2025.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.